Pharvaris BV is a biotechnology business based in the US. Pharvaris BV shares (PHVS) are listed on the NASDAQ and all prices are listed in US Dollars. Pharvaris BV employs 56 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy Pharvaris BV stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – PHVS. It's that simple.
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
Robinhood
- Get free stock upon signup
- Earn 4% interest on uninvested cash with Robinhood Gold
- Get 1% match on contributions to a Robinhood IRA
tastyworks
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.
Pharvaris BV stock price (NASDAQ: PHVS)
Use our graph to track the performance of PHVS stocks over time.Pharvaris BV shares at a glance
Latest market close | $9.10 |
---|---|
52-week range | $1.77 - $27.50 |
50-day moving average | $7.04 |
200-day moving average | $12.84 |
Wall St. target price | $17.42 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-1.52 |
Buy Pharvaris BV stocks from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Pharvaris BV stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Pharvaris BV price performance over time
Historical closes compared with the close of $9.1 from 2023-01-30
1 week (2023-01-24) | -9.99% |
---|---|
1 month (2022-12-30) | -19.11% |
3 months (2022-11-01) | 116.67% |
6 months (2022-08-01) | -54.50% |
1 year (2022-02-01) | -46.47% |
---|---|
2 years (2021-01-28) | N/A |
3 years (2020-01-28) | N/A |
5 years (2018-01-28) | N/A |
Pharvaris BV financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -23.91% |
Return on equity TTM | -25.37% |
Profit margin | 0% |
Book value | $5.48 |
Market capitalisation | $324.7 million |
TTM: trailing 12 months
Pharvaris BV share dividends
We're not expecting Pharvaris BV to pay a dividend over the next 12 months.
Pharvaris BV overview
Pharvaris N. V. , a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, rapid exposure soft capsule for patients suffering from acute HAE attacks and is under Phase 2 clinical trial; and PHVS719, a prophylactic extended-release tablet for HAE patients and is under Phase 1 clinical trial. It operates in the Netherlands, Switzerland, and the United States. The company was incorporated in 2015 and is based in Leiden, the Netherlands.
Pharvaris BV in the news
Pharvaris N.V.'s (NASDAQ:PHVS) largest shareholders are private equity firms with 44% ownership, institutions own 26%
Pharvaris Provides Regulatory, Clinical, and Corporate Updates
Pharvaris Provides Regulatory, Clinical, and Corporate Updates
Frequently asked questions
What percentage of Pharvaris BV is owned by insiders or institutions?Currently 9.626% of Pharvaris BV shares are held by insiders and 76.853% by institutions. How many people work for Pharvaris BV?
Latest data suggests 56 work at Pharvaris BV. When does the fiscal year end for Pharvaris BV?
Pharvaris BV's fiscal year ends in December. Where is Pharvaris BV based?
Pharvaris BV's address is: J.H. Oortweg 21, Leiden, Netherlands, 2333 CH What is Pharvaris BV's ISIN number?
Pharvaris BV's international securities identification number is: NL00150005Y4
More guides on Finder
-
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
-
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
-
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
-
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
-
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
-
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
-
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
-
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
-
How to research stocks
Learn about stock analysis and how to use it to find the right company to buy.
Ask an Expert